Early age-related maculopathy in the cardiovascular health study

Ophthalmology

Volumn 110, Issue 1, 2003, Pages 25-33

  Klein, Ronald ^a   Klein, Barbara E K ^a   Hubbard, Larry D ^a   Marino, Emily K ^b   Kuller, Lewis H ^c   Furberg, Curt ^d   Burke, Gregory L ^d  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

^c UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

^d WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LIPID;

AGE; AGED; ARTICLE; ATHEROSCLEROSIS; CALORIC INTAKE; CARDIOVASCULAR RISK; CEREBELLUM DISEASE; DISEASE ASSOCIATION; DRUSEN; EYE PHOTOGRAPHY; FEMALE; GENDER; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; POPULATION RESEARCH; PREVALENCE; PRIORITY JOURNAL; RACE; RETINA MACULA AGE RELATED DEGENERATION; UNITED STATES;

EID: 0037228021     PISSN: 01616420     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0161-6420(02)01565-8     Document Type: Article

References (58)

1. National Society to Prevent Blindness. Vision Problems in the US: Data Analysis. New York: National Society to Prevent Blindness, 1980;1-46.
2. Klein R, Wang Q, Klein BEK, et al. The relationship of age-related maculopathy, cataract, and glaucoma to visual acuity. Invest Ophthalmol Vis Sci 1995;36:182-91.
3. Klein R, Klein BEK, Lee KP. Changes in visual acuity in a population. The Beaver Dam Eye Study. Ophthalmology 1996;103:1169-78.
4. Laser photocoagulation of subfoveal neovascular lesions of age-related macular degeneration. Updated findings from two clinical trials. Macular Photocoagulation Study Group. Arch Ophthalmol 1993;111:1200-9.
5. Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin one-year results of 2 randomized clinical trials-TAP Report 1. Treatment of Age-related Macular Degeneration with Photodynamic Therapy (TAP) Study Group [published erratum appears in Arch Ophthalmol 2000;18:488]. Arch Ophthalmol 1999;117:1329-45.
6. Klein R. Epidemiology. In: Berger JW, Fine SL, Maguire MG, eds. Age-related Macular Degeneration. St. Louis: Mosby, 1999;31-55.
7. Friedman E. Pathogenesis: A hemodynamic model. In: Berger JW, Fine SL, Maguire MG, eds. Age-related Macular Degeneration. St. Louis: Mosby, 1999;173-8.
8. Potts AM. An hypothesis on macular disease. Trans Am Acad Ophthalmol Otolaryngol 1966;70:1058-62.
9. Bischoff PM, Flower RW. High blood pressure in choroidal arteries as a possible pathogenetic mechanism in senile macular degeneration [letter]. Am J Ophthalmol 1983;96:398-9.
10. Holz FG, Sheraidah G, Pauleikhoff D, Bird AC. Analysis of lipid deposits extracted from human macular and peripheral Bruch's membrane. Arch Ophthalmol 1994;112:402-6.
11. Maltzman BA, Mulvihill MN, Greenbaum A. Senile macular degeneration and risk factors: A case-control study. Ann Ophthalmol 1979;11:1197-201.
12. Delaney WV Jr, Oates RP. Senile macular degeneration: A preliminary study. Ann Ophthalmol 1982;14:21-4.
13. Hyman LG, Lilienfeld AM, Ferris FL III, Fine SL. Senile macular degeneration: A case-control study. Am J Epidemiol 1983;118:213-27.
14. Vidaurri JS, Pe'er J, Halfon ST, et al. Association between drusen and some of the risk factors for coronary artery disease. Ophthalmologica 1984;188:243-7.
15. Blumenkranz MS, Russell SR, Robey MG, et al. Risk factors in age-related maculopathy complicated by choroidal neovascularization. Ophthalmology 1986;93:552-8.
16. Risk factors for neovascular age-related macular degeneration. The Eye Disease Case-Control Study Group. Arch Ophthalmol 1992;110:1701-8.
17. Sperduto RD, Hiller R. Systemic hypertension and age-related maculopathy in the Framingham Study. Arch Ophthalmol 1986;104:216-9.
18. Klein R, Klein BEK, Franke T. The relationship of cardiovascular disease and its risk factors to age-related maculopathy. The Beaver Dam Eye Study. Ophthalmology 1993;100:406-14.
19. Vingerling JR, Dielemans I, Bots ML, et al. Age-related macular degeneration is associated with atherosclerosis. The Rotterdam Study. Am J Epidemiol 1995;142:404-9.
20. Klein BEK, Klein R. Cataracts and macular degeneration in older Americans. Arch Ophthalmol 1982;100:571-3.
21. Albrink MJ, Fasanella RM. Serum lipids in patients with senile macular degeneration. Am J Ophthalmol 1963;55:709-13.
22. Goldberg J, Flowerdew G, Smith E, et al. Factors associated with age-related macular degeneration. An analysis of data from the first National Health and Nutrition Examination Survey. Am J Epidemiol 1988;128:700-10.
23. Klein R, Klein BEK, Jensen SC. The relation of cardiovascular disease and its risk factors to the 5-year incidence of age-related maculopathy: The Beaver Dam Eye Study. Ophthalmology 1997;104:1804-12.
24. Smith W, Mitchell P, Leeder SR, Wang JJ. Plasma fibrinogen levels, other cardiovascular risk factors, and age-related maculopathy: The Blue Mountains Eye Study. Arch Ophthalmol 1998;116:583-7.
25. Cruickshanks KJ, Hamman RF, Klein R, et al. The prevalence of age-related maculopathy by geographic region and ethnicity. The Colorado-Wisconsin Study of Age-Related Maculopathy. Arch Ophthalmol 1997;115:242-50.
26. Klein R, Klein BEK, Jensen SC, et al. Age-related maculopathy in a multiracial United States population: The National Health and Nutrition Examination Survey III. Ophthalmology 1999;106:1056-65.
27. Klein R, Clegg L, Cooper LS, et al. Prevalence of age-related maculopathy in the Atherosclerosis Risk in Communities Study. Arch Ophthalmol 1999;117:1203-10.
28. Hyman L, Schachat AP, He Q, Leske MC. Hypertension, cardiovascular disease, and age-related macular degeneration. Age-related Macular Degeneration Risk Factors Study Group. Arch Ophthalmol 2000;35:1-8.
29. Sarks SH. Patterns in Macular Degeneration: Retinal Disease. New York: Grune & Stratton, 1985;87-93.
30. Penfold PL, Killingsworth MC, Sarks SH. Senile macular degeneration: The involvement of giant cells in atrophy of the retinal pigment epithelium. Invest Ophthalmol Vis Sci 1986; 27:364-71.
31. Mares-Perlman JA, Klein R, Klein BEK, et al. Association of zinc and antioxidant nutrients with age-related maculopathy. Arch Ophthalmol 1996;114:991-7.
32. Mares-Perlman JA, Brady WE, Klein R, et al. Dietary fat and age-related maculopathy. Arch Ophthalmol 1995;113:743-8.
33. Mares-Perlman JA, Klein R. Diet and age-related macular degeneration. In: Taylor A, ed. Nutritional and Environmental Influences on the Eye. Boca Raton, FL: CRC Press, 1999; chap. 11, 181-214.
34. Fried LP, Borhani NO, Enright P, et al. The Cardiovascular Health Study: Design and rationale. Ann Epidemiol 1991;1: 263-76.
35. Tell GS, Fried LP, Hermanson B, et al. Recruitment of adults 65 years and older as participants in the Cardiovascular Health Study. Ann Epidemiol 1993;3:358-66.
36. Atherosclerosis Risk in Communities (ARIC) Study Research Group. ARIC Retinal Photography Protocol, Manual 14A, and ARIC Reading Center protocol, Manual 14 B. Available from the ARIC Coordinating Center, Department of Biostatistics (CSCC), Chapel Hill, NC: University of North Carolina, CB#8030.
37. Rimm EB, Giovannucci EL, Stampfer MJ, et al. Reproducibility and validity of an expanded self-administered semiquantitative food frequency questionnaire among male health professionals. Am J Epidemiol 1992;135:1114-26; discussion 1127-36.
38. Klein R, Davis MD, Magli YL, Klein BEK. Wisconsin Age-Related Maculopathy Grading System. Madison WI: University of Wisconsin Medical School, Dept. of Ophthalmology and Visual Sciences, 1991.
39. Klein R, Davis MD, Magli YL, et al. The Wisconsin age-related maculopathy grading system. Ophthalmology 1991;98: 1128-34.
40. Hubbard LD, Brothers RJ, King WN, et al. Methods for evaluation of retinal microvascular abnormalities associated with hypertension/sclerosis in the Atherosclerosis Risk in Communities Study. Ophthalmology 1999;106:2269-80.
41. O'Leary DH, Polak JF, Wolfson SK Jr. Use of sonography to evaluate carotid atherosclerosis in the elderly. The Cardiovascular Health Study. CHS Collaborative Research Group. Stroke 1991;22:1155-63.
42. Manolio TA, Kronmal RA, Burke GL, et al. Magnetic resonance abnormalities and cardiovascular disease in older adults. The Cardiovascular Health Study. Stroke 1994;25: 318-27.
43. Furberg CD, Manolio TA, Psaty BM, et al. Major electrocardiographic abnormalities in persons age 65 years and older (the Cardiovascular Health Study). Cardiovascular Health Study Collaborative Research Group. Am J Cardiol 1992;69: 1329-35.
44. Kuller L, Borhani N, Furberg C, et al. Prevalence of subclinical atherosclerosis and cardiovascular disease and association with risk factors in the Cardiovascular Health Study. Am J Epidemiol 1994;139:1164-79.
45. Dithmar S, Sharara NA, Curcio CA, et al. Murine high-fat diet and laser photochemical model of basal deposits in Bruch membrane. Arch Ophthalmol 2001;119:1643-9.
46. Curcio CA, Millican CL, Bailey T, Kruth HS. Accumulation of cholesterol with age in human Bruch's membrane. Invest Ophthalmol Vis Sci 2001;42:265-74.
47. Hayes KC, Lindsey S, Stephan ZF, Brecker D. Retinal pigment epithelium possesses both LDL and scavenger receptor activity. Invest Ophthalmol Vis Sci 1989;30:225-32.
48. Goldstein JL, Hobbs HH, Brown MS. Familial hypercholesterolemia. In: Scriver CR, Beaudet AL, Valle D, Sly WS, eds. The Metabolic and Molecular Basis of Inherited Disease, 8th ed. New York: McGraw-Hill, 2001; v. 2, 2863-913.
49. Kahn HA, Leibowitz HM, Ganley JP, et al. The Framingham Eye Study. II. Association of ophthalmic pathology with single variables previously measured in the Framingham Heart Study. Am J Epidemiol 1977;106:33-41.
50. Klein R, Klein BEK, Cruickshanks KJ. The prevalence of age-related maculopathy by geographic region and ethnicity. Prog Retin Eye Res 1999;18:371-89.
51. Schachat AP, Hyman L, Leske MC, et al. Features of age-related macular degeneration in a black population. The Barbados Eye Study Group. Arch Ophthalmol 1995;113:728-35.
52. Jampol LM, Tielsch J. Race, macular degeneration, and the Macular Photocoagulation Study [editorial]. Arch Ophthalmol 1992;110:1699-700.
53. Rohan RM, Fernandez A, Udagawa T, et al. Genetic heterogenity of angiogenesis in mice. FASEB J 2000;14:871-6.
54. Age-Related Eye Disease Study Research Group. A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss: AREDS report no. 8. Arch Ophthalmol 2001;119:1417-36.
55. Mitchell P, Smith W, Attebo K, Wang JJ. Prevalence of age-related maculopathy in Australia. The Blue Mountains Eye Study. Ophthalmology 1995;102:1450-60.
56. Vingerling JR, Dielemans I, Hofman A, et al. The prevalence of age-related maculopathy in the Rotterdam Study. Ophthalmology 1995;102:205-10.
57. Klein R, Meuer SM, Moss SE, Klein BEK. Detection of drusen and early signs of age-related maculopathy using a nonmydriatic camera and a standard fundus camera. Ophthalmology 1992;99:1686-92.
58. Klein R, Klein BEK, Moss SE. Age-related eye disease and survival. The Beaver Dam Eye Study. Arch Ophthalmol 1995; 113:333-9.